Results 131 to 140 of about 12,119 (223)

Biomarkers for satralizumab treatment in neuromyelitis optica spectrum disorders: a prospective case series. [PDF]

BMC Neurol
Hu S, Wang X, Wu H, Hong R, Xiao X, Zhao Y, Li R.   +6 more
europepmc   +1 more source

Causal Exposures of Immune Cells in Neuromyelitis Optica Spectrum Disorders: A Mendelian Randomization Study and Flow Cytometry Analysis. [PDF]

Brain Behav
Ren J, Wang J, Niu Z, Guo J, Zhang N, Hao H, Gao F, Liu R, Wang Z.   +8 more
europepmc   +1 more source

Large language models as clinical decision-support tools in multiple sclerosis and neuromyelitis optica spectrum disorders: A comparative study of ChatGPT-4o and neurologists. [PDF]

Mult Scler J Exp Transl Clin
Saposnik G, Solanes A, Monreal E, Sepúlveda M, Hernández MÁ, Cuello JP, Álvarez-Bravo G, Agüera-Morales E, Riancho J, Pérez-Sempere Á, Maurino J, Gómez-Ballesteros R.   +11 more
europepmc   +1 more source

Peripheral blood immune inflammatory markers in neuromyelitis optica spectrum disorders. [PDF]

Front Neurol
Wu B, Cao F, Mao M, Gong X, Xu B.
europepmc   +1 more source

Novel B-Cell targeting therapy with subcutaneous of atumumab in AQP4-IgG-seronegative Neuromyelitis Optica Spectrum Disorders: efficacy and personalized dosing. [PDF]

Front Immunol
Cao X, Qin D, Wang B, Wang C, Guo S.
europepmc   +1 more source

Efficacy and Safety of Telitacicept and Mycophenolate Mofetil in the Treatment of Neuromyelitis Optica Spectrum Disorders. [PDF]

Ann Indian Acad Neurol
Zuo S, Yang W, Wang X, Zhang M, Dong Z, Chen X, Li W.   +6 more
europepmc   +1 more source

Health Technology Assessment: Evaluation of Monoclonal Antibodies for the Treatment of Neuromyelitis Optica Spectrum Disorders. [PDF]

Drug Des Devel Ther
Wang C, Wu H, Huang Y, Liu A, Lai S.
europepmc   +1 more source

Atypical Multiple Sclerosis Overlapping Features of Neuromyelitis Optica Spectrum Disorders (NMOSD). [PDF]

Clin Case Rep
Paybast S, Emami A, Rezaeimanesh N, Naser Moghadasi A.   +3 more
europepmc   +1 more source

PPAR-γ activation by pioglitazone inhibits microglia-mediated neuroinflammation and alleviates disease in neuromyelitis optica spectrum disorders. [PDF]

Acta Neuropathol Commun
Yick LW, Chan EYY, Zou W, Yau KX, Kwan JSC, Lee CY, Chan KH.   +6 more
europepmc   +1 more source

Neuromyelitis optica spectrum disorder

, 2008
Frank Gaillard, Rohit Sharma, Arlene Campos   +2 more
openaire   +1 more source